Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 650 de 1158 resultados encontrados
Opções avançadas
Data de publicação: 28/02/2021 - 15:54
Estudo preliminar, ainda em preprint, demonstra eficácia da vacina de Oxford. Pesquisadores escoceses realizaram o primeiro estudo sobre a eficácia da vacina produzida pela farmacêutica AstraZeneca, a mesma que a Fiocruz tem parceria, em condições reais. Eles analisaram um conjunto de dados cobrindo toda a população escocesa de 5,4 milhões, dos quais 1,3 milhão foram...
Documento/Arquivo
Data de publicação: 25/02/2021 - 15:12
The genomic surveillance in Brazil gains a reinforcement with the new assay for the Sars-CoV-2 strains detection, by means of the RT-PCR protocol, developed by researchers from the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia). The tool was announced by the researcher and vice director of Research and Innovation at Fiocruz Amazônia, Felipe Naveca. The new trial allows screening of the most important strains in...
Notícias
Data de publicação: 25/02/2021 - 13:22
The Fiocruz Genomic Network is participating in a project by the Ministry of Health that will sequence new coronavirus samples throughout the national territory. Currently, only three central laboratories (Lacens) in the states are capable of this task. The Network brings together researchers from various institutes of the Foundation to study genetics and genomes of viruses, bacteria, fungi, parasites, and humans, in addition to receiving...
Notícias
Data de publicação: 25/02/2021 - 11:42
On February 5, the Ministry of Health (MoH) and Fiocruz launched a public notice for the construction of the Industrial Complex of Biotechnology in Health (Cibs, in the Portuguese acronym). The document opens a bidding process for hiring investors interested in participating in the construction of a new complex of the Immunobiological Technology Institute of the Oswaldo Cruz Foundation (Bio-Manguinhos/Fiocruz), in Santa Cruz, in Rio de Janeiro....
Notícias
Data de publicação: 05/02/2021 - 10:57
A project of Fiocruz Pernambuco was selected in a public call released by the Federal Government in a partnership with other countries that are part of BRICS - formed by Brazil, Russia, India, China and South Africa. The public notice’s resources had R$6.2 million provided by the Ministry of Science, Technology and Innovation and R$1 million provided byt the Ministry of Health to fund researches directed to facing the Covid-19 pandemic...
Notícias
Data de publicação: 05/02/2021 - 10:19
On the side of Maici river (Aldeia Dudu), an indigenous woman called Potai Pirahã received the first dose of the Covid-19 vaccine. Aftere 28 days, she should get the second dose. Potai Pirahã is part of a group of 713 indigenous people that will be vaccinated in the municipality of Humaitá (in the South of Amazonas). The vaccination in indigenous lands of the area started on January 26th, along with lectures to raise...
Notícias
Data de publicação: 05/02/2021 - 10:09
On January 29th, Fiocruz officially submited the application to register the Covid-19 vaccine to the Healthy Surveillance Agency (Anvisa), which will allow the Oxford-AstraZeneca immunizer Covid-19 vaccine across the country. “This is another key step in facing the pandemic and it will allow the Brazilian population to have broad access to the vaccine, which will be distributed through the Ministry of Health’s National Immunization...
Notícias
Data de publicação: 03/02/2021 - 12:41
Gender & Covid-19: How to create a genderresponsive pandemic plan - Addressing the secondary effects of COVID-19 (documento em ingês) Autores: Erica N. Rosser, Rosemary Morgan, Heang-Lee Tan, Kate Hawkins, Anne Ngunjiri, Amy Oyekunle, Brunah Schall, Denise Nacif Pimenta, Eduardo Tamaki, Mariela Rocha, Clare Wenham. Confira mais informações no Observatório Covid-19. Acesse o especial da Fiocruz...
Documento/Arquivo
Data de publicação: 25/01/2021 - 12:53
In a partnership with the Amazonas Foundation for Health Surveillance (FVS-AM), researchers of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazon) have confirmed the second case of reinfection by the Sars-CoV-2 in Brazil. The reinfection occurred in manaus, capital of the state of Amazonas, by the new variant identified in the state, designateed B.1.1.28.1 or P.1. The case was confirmed by virologist and researcher Felipe Naveca....
Notícias
Data de publicação: 25/01/2021 - 12:46
Analyzing the characteristics of patients hospitalized due to Covid-19 in Brazil and examining the impact of the disease in the use of resources and in hospital mortality were the goals of the study that assessed the first 250 thousand hospitalizations due to Covid-19 in Brazil, between February 16 and August 15, 2020. “The work has two great contributions to give: documenting the effect of the epidemic on the Brazilian population and on...
Notícias
Data de publicação: 22/01/2021 - 11:55
At the end of the 1st Extraordinary Public Meeting of the Collegiate Board, held on January 17, the Brazilian Health Regulatory Agency (Anvisa) authorized the emergency use of two vaccines against Covid-19: Oxford-AstraZeneca, Fiocruz, and Coronavac, of the Butantan Institute. A historic day for Anvisa and also for Brazil, marking the beginning of vaccination in the country. The emergency request submitted by Fiocruz refers to the 2...
Notícias
Data de publicação: 19/01/2021 - 16:06
Preservation Policy Scientific and cultural collections of Fiocruz
Documento/Arquivo
Data de publicação: 15/01/2021 - 09:41
A researcher of the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) confirms the identification of the origin of the new variant of the Sars-CoV-2 in Amazonas. The new variant was provisionally named B.1.1.28 (K417N / E484K / N501Y). Led by Felipe Naveca, the study suggests that the strains, identified in Japanese travelers that had been in the Amazonian region, evolved from a viral strain in Brazil that is...
Notícias
Data de publicação: 15/01/2021 - 09:21
Nísia Trindade Lima was renominated for the position of President of Fiocruz, for the period of 2021-2024. Lima was elected on the first place of the three-name list unanimously homologated by Fiocruz Advisory Board, which was handed to the Health Minister, Eduardo Pazuello, last November. Fiocruz 2020 elections were the most significant in the institution’s history, with the participation of 4,400 voters - 91.6% of the 4,847...
Notícias
Data de publicação: 08/01/2021 - 14:20
Since the beginning of the pandemic, the Oswaldo Cruz Foundation (Fiocruz) has been promoting efforts to save lives and contribute to vaccinate Brazilians as soon as possible. The search for doses of the vaccine against Covid-19 has always been on the table during negotiations with AstraZeneca. At a recent meeting with the Ministry of Health and Fiocruz, AstraZeneca presented the current scenario and the feasibility of delivering to the...
Notícias
Data de publicação: 04/01/2021 - 14:54
In its efforts against the pandemic, Fiocruz researchers have observed that memory for the immune response against the coronavirus, which would prevent reinfection, may not occur in mild cases. The discovery took place after sequencing the genotypes of the new coronavirus, and reinforces the fact that reinfection by the Sars-CoV-2 is possible. Viral Genetic Evidence and Host Immune Response of a Small Cluster of Individuals with Two...
Notícias
Data de publicação: 18/12/2020 - 16:04
Boletim Internacional
Data de publicação: 18/12/2020 - 14:24
Representatives of Fiocruz and of the British Embassy met on December 15 to discuss cooperation in health between the Foundation and institutions of the United Kingdom. At the meeting, requested by the embassy’s business manager, Liv Davidson, and with the presence of the British consul in Rio de Janeiro, Simon Wood, the attendees discussed current partnerships and possible new ones. The main cooperation of Fiocruz with British...
Notícias
Data de publicação: 18/12/2020 - 12:21
After five years of research, a project led by Fiocruz has reached encouraging results in the search for a therapy to prevent congenital zika syndrome. In an article published on Antiviral Research, the authors show an intense protective effect of sofosbuvir, the antiviral drug currently indicated to treat hepatitis C. In trials with Rhesus monkeys, considered to be the experimental model closest to humans, the drug prevented zika virus...
Notícias
Data de publicação: 18/12/2020 - 11:42
Most times a pregnant woman goes through a viral infection, such as a common cold, the baby remains protected in the womb. This protection is provided by the placenta, the organ that connects mother and baby and works as a barrier against microorganisms. However, there are pathogens that can overcome this barrier. One example is the zika virus. In 2015 and 2016, it caused a public health emergency of international relevance due to its...
Notícias
Data de publicação: 17/12/2020 - 16:11
At the Ordinary General Assembly held on December 3, the Board of Directors of the Brazilian Academy of Sciences (ABC, in the Portuguese acronym) released the results of the elections to full members, correspondents, employees, and affiliates. The president of Fiocruz, Nísia Trindade Lima, was elected a full member in the Social Sciences category. And researcher Milena Botelho Pereira Soares, from Fiocruz Bahia, was elected a full member...
Notícias
Data de publicação: 16/12/2020 - 16:31
The Oswaldo Cruz Foundation, through the Institute of Technology in Immunobiologicals (Bio-Manguinhos), signed with the Government of the State of Rio de Janeiro, this Thursday (3/12), the final deed of the land where the Industrial Complex of Biotechnology in Health (Cibs) is being built, in the Industrial District of Santa Cruz, in Rio de Janeiro. The ceremony took place at the Guanabara Palace, the head office of the Rio de Janeiro government...
Notícias
Data de publicação: 16/12/2020 - 11:20
As made public by the Ministry of Health and by the Secretaries of Health of the states of Paraíba and Rio Grande do Norte, the Oswaldo Cruz Foundation has confirmed the first case of reinfection by the new coronavirus (Sars-CoV-2) in the country. The samples, obtained from a healthcare worker residing in the city of Natal, capital of Rio Grande do Norte, and who works in both states, were analyzed by the Laboratory of Respiratory Viruses...
Notícias
Data de publicação: 10/12/2020 - 16:13
The Oswaldo Cruz Foundation received on Monday (7/12) the visit of the Ambassador of India to Brazil, Suresh K. Reddy. The embassy delegation was received by the president of Fiocruz, Nísia Trindade Lima, for a meeting in which the main topic was cooperation in the field of pharmaceuticals. The Indian ambassador and the president of Fiocruz addressed the prospect of new partnerships in health (Photo: Pedro Paulo Gonçalves...
Notícias
Data de publicação: 10/12/2020 - 13:46
During the pandemic, 48.7% of teenagers in the country have felt worried, nervous, or in a bad mood, most of the time or always. There was an increase in the consumption of sweets and frozen foods, as well as in sedentary lifestyle: the percentage of young people who did not do 60 minutes of physical activity on any day of the week before the pandemic was 20.9%, and increased to 43.4%. Seventy percent of Brazilians aged 16 to 17 started to spend...
Notícias

Pages

Back to the topBack